Congress demands public strategy to disrupt Middle East drug networks funding terror groups
H.R. 7180 — Countering Captagon and Narcotics Post-Assad Act · Filed by J. Hill (R-AR) · 2 cosponsors · Introduced Jan 21, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends the 2023 National Defense Authorization Act to require the U.S. government to develop a detailed, unclassified strategy for disrupting Captagon and methamphetamine production and trafficking in the Middle East, particularly following the fall of Assad's regime in Syria. The strategy must assess which countries are receiving or producing these drugs, evaluate local counter-narcotics capacity, review U.S. assistance programs, and recommend actions to dismantle networks linked to Assad, Hezbollah, and Iran-backed groups.
Why we flagged it
The bill's operative mechanism is a requirement for an interagency strategy document addressing drug trafficking in the Middle East post-Assad. It is a policy-coordination and transparency measure, not a regulatory carve-out, appropriation, or commemorative act.
What the text implies
- The bill's focus on Captagon and amphetamine-type stimulants in the post-Assad vacuum may implicitly signal a shift in U.S. counter-narcotics priorities toward Middle Eastern production hubs, potentially affecting resource allocation away from other regions or drug types.
- Requiring assessment of 'cooperation with international partners' and 'counter-narcotics capacity' of regional states may create diplomatic leverage or conditionality for U.S. military and law enforcement assistance in the region.
The full analysis lists 3 implications of this text.
Who it affects
The bill mandates transparency and strategic planning around a genuine regional security threat (drug trafficking funding destabilizing actors and terrorist networks), requiring an unclassified written strategy that Congress and the public can scrutinize. It does not create new restrictions on citizens' rights or shield officials from accountability.